摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

benzo[d]isoxazol-3-yl-(4-(4-chlorophenoxy)piperidin-1-yl)methanone | 1304781-43-8

中文名称
——
中文别名
——
英文名称
benzo[d]isoxazol-3-yl-(4-(4-chlorophenoxy)piperidin-1-yl)methanone
英文别名
Benzo[d]isoxazol-3-yl(4-(4-chlorophenoxy)piperidin-1-yl)methanone;1,2-benzoxazol-3-yl-[4-(4-chlorophenoxy)piperidin-1-yl]methanone
benzo[d]isoxazol-3-yl-(4-(4-chlorophenoxy)piperidin-1-yl)methanone化学式
CAS
1304781-43-8
化学式
C19H17ClN2O3
mdl
——
分子量
356.809
InChiKey
UBFLZTIKXVYQCI-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.3
  • 重原子数:
    25
  • 可旋转键数:
    3
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.26
  • 拓扑面积:
    55.6
  • 氢给体数:
    0
  • 氢受体数:
    4

反应信息

  • 作为产物:
    描述:
    benzisoxazole-3-carboxylic acid chloride4-(4-氯苯氧基)哌啶N,N-二异丙基乙胺 作用下, 以 二氯甲烷 为溶剂, 反应 1.0h, 以37%的产率得到benzo[d]isoxazol-3-yl-(4-(4-chlorophenoxy)piperidin-1-yl)methanone
    参考文献:
    名称:
    [EN] ARYL CARBOXAMIDE DERIVATIVES AS TTX-S BLOCKERS
    [FR] DÉRIVÉS D'ARYLCARBOXAMIDE COMME BLOQUEURS DE TTX-S
    摘要:
    本发明涉及式(I)的芳基羧酰胺衍生物,其中Ar1为苯基;Ar2为芳基;n为1-4;X为-O-、-S-、-SO-或-SO2-,其前体药物或其药学上可接受的盐,具有作为TTX-S通道的电压门控钠通道的阻塞活性,并且在治疗或预防涉及电压门控钠通道的疾病和疾病中如疼痛等方面具有用途。该发明还涉及包含这些化合物的药物组合物以及这些化合物和组合物在预防或治疗涉及电压门控钠通道的疾病如疼痛中的用途。
    公开号:
    WO2011058766A1
点击查看最新优质反应信息

文献信息

  • ARYL CARBOXAMIDE DERIVATIVES AS TTX-S BLOCKERS
    申请人:Yamagishi Tatsuya
    公开号:US20120232052A1
    公开(公告)日:2012-09-13
    The present invention relates to aryl carboxamide derivatives of formula (I), wherein Ar 1 is phenyl; Ar 2 is aryl; n is 1-4; X is —O—, —S—, —SO— or —SO 2 —, a prodrug thereof or a pharmaceutically acceptable salt thereof, which have blocking activities of voltage gated sodium channels as the TTX-S channels, and which are useful in the treatment or prevention of such disorders and diseases as pain in which voltage gated sodium channels are involved. The invention also relates to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases as pain in which voltage gated sodium channels are involved.
    本发明涉及公式(I)的芳基羧酰胺衍生物,其中Ar1是苯基;Ar2是芳基;n为1-4;X为—O—、—S—、—SO—或—SO2—,其前体药物或其药学上可接受的盐,具有阻断电压门控钠通道如TTX-S通道的活性,并在治疗或预防涉及电压门控钠通道的疾病和疾病,如疼痛方面中有用。本发明还涉及包含这些化合物的制药组合物以及这些化合物和组合物在预防或治疗涉及电压门控钠通道的疾病和疾病,如疼痛方面的使用。
  • Aryl carboxamide derivatives as TTX-S blockers
    申请人:Yamagishi Tatsuya
    公开号:US09051296B2
    公开(公告)日:2015-06-09
    The present invention relates to aryl carboxamide derivatives of formula (I), wherein Ar1 is phenyl; Ar2 is aryl; n is 1-4; X is —O—, —S—, —SO— or —SO2—, a prodrug thereof or a pharmaceutically acceptable salt thereof, which have blocking activities of voltage gated sodium channels as the TTX-S channels, and which are useful in the treatment or prevention of such disorders and diseases as pain in which voltage gated sodium channels are involved. The invention also relates to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases as pain in which voltage gated sodium channels are involved.
    本发明涉及式(I)的芳基羧酰胺衍生物,其中Ar1为苯基;Ar2为芳基;n为1-4;X为—O—,—S—,—SO—或—SO2—,其前药或其药学上可接受的盐具有钠离子通道阻滞活性,特别是TTX-S通道,可用于治疗或预防涉及钠离子通道的疾病和疾病,如疼痛。本发明还涉及包含这些化合物的制药组合物以及这些化合物和组合物在预防或治疗涉及钠离子通道的疾病和疾病,如疼痛中的用途。
  • US9051296B2
    申请人:——
    公开号:US9051296B2
    公开(公告)日:2015-06-09
  • [EN] ARYL CARBOXAMIDE DERIVATIVES AS TTX-S BLOCKERS<br/>[FR] DÉRIVÉS D'ARYLCARBOXAMIDE COMME BLOQUEURS DE TTX-S
    申请人:RAQUALIA PHARMA INC
    公开号:WO2011058766A1
    公开(公告)日:2011-05-19
    The present invention relates to aryl carboxamide derivatives of formula (I), wherein Ar1 is phenyl; Ar2 is aryl; n is 1-4; X is -O-, -S-, -SO- or -SO2-, a prodrug thereof or a pharmaceutically acceptable salt thereof, which have blocking activities of voltage gated sodium channels as the TTX-S channels, and which are useful in the treatment or prevention of such disorders and diseases as pain in which voltage gated sodium channels are involved. The invention also relates to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases as pain in which voltage gated sodium channels are involved.
    本发明涉及式(I)的芳基羧酰胺衍生物,其中Ar1为苯基;Ar2为芳基;n为1-4;X为-O-、-S-、-SO-或-SO2-,其前体药物或其药学上可接受的盐,具有作为TTX-S通道的电压门控钠通道的阻塞活性,并且在治疗或预防涉及电压门控钠通道的疾病和疾病中如疼痛等方面具有用途。该发明还涉及包含这些化合物的药物组合物以及这些化合物和组合物在预防或治疗涉及电压门控钠通道的疾病如疼痛中的用途。
查看更多

同类化合物

苯并异恶唑Hsp90抑制剂 苯并[d]异噁唑-7-醇 苯并[d]异噁唑-5-胺 苯并[d]异噁唑-5-磺酰氯 苯并[D]异恶唑-3-甲酸 苯[D]异恶唑-3-醇 羟基伊洛哌酮 甲基6-氨基-1,2-苯并恶唑-3-羧酸酯 环己酮,2,3-二甲基-6-(1-甲基乙基)-,[2R-(2α,3ba,6ba)]-(9CI) 帕潘立酮杂质1 奈氟齐特 四氢-4-[[[4-[[[4-[[(3R)-四氢-3-呋喃基]氧基]-1,2-苯并恶唑-3-基]氧基]甲基]-1-哌啶基]甲基]-2H-吡喃-4-醇 唑尼酰胺-d4 唑尼沙胺钠 唑尼沙胺13C2-15N 唑尼沙胺 呋喃并[3,4:3,4]环丁二烯并[1,2:3,4]环丁二烯并[1,2-d]异噻唑(9CI) 呋喃并[3,4-f][1,2]苯并恶唑 呋喃并[3,4-e][1,2]苯并恶唑 呋喃并[3,2-g][1,2]苯并恶唑 呋喃并[3,2-f]-1,2-苯并异恶唑 呋喃并[2,3-f][1,2]苯并恶唑 呋喃并[2,3-e][1,2]苯并恶唑 叔-丁基(6-溴苯并[D]异噻唑-3-基)氨基甲酯 化合物 T29498 佐尼氯唑 伊潘立酮(R)-羟基杂质 alpha-甲基-3-苯基-1,2-苯并异恶唑-7-乙酸 [1,2]恶唑并[5,4-f][1,2]苯并恶唑 [1,2]恶唑并[5,4-e][2,1,3]苯并恶二唑 [1,1'-联苯基]-3-醇,2'-(5-乙基-3,4-二苯基-1H-吡唑-1-基)- [(3-氨基-1,2-苯并异恶唑-5-基)甲基]氨基甲酸叔丁酯 N,N-二甲基唑尼沙胺杂质 N-甲氧基-N-甲基苯并[d]异恶唑-3-甲酰胺 N-甲基唑尼沙胺 N-乙基苯异恶唑酮四氟硼酸盐 N-[(1,2-苯并恶唑-3-基甲基)磺酰基]乙酰胺 N-(苯并[D]异恶唑-3-基氧基-二甲基氨基-磷酰)-N-甲基-甲胺 N-(6-己酸)唑尼沙胺 7-硝基-1,2-苯并恶唑 7-甲氧基-3-甲基-1,2-苯并恶唑 7-甲基苯并[d]异恶唑-3-醇 7-溴苯并[d]异噁唑 7-溴苯并[D]异恶唑-3(2H)-酮 7-溴-3-氯苯并[D]异恶唑 7-溴-1,2-苯并恶唑-3-胺 7-氯-苯并[d]异恶唑 7-氟苯并[d]异噁唑-3-胺 7-氟-苯并[d]异噁唑-3-醇 6-苯基苯并[d]异噁唑-3-胺